Chilton Investment Company’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-120,000
Closed -$1.32M 134
2017
Q1
$1.32M Buy
+120,000
New +$1.65M 0.05% 90
2015
Q1
Sell
-54,509
Closed -$7.8M 144
2014
Q4
$7.8M Hold
54,509
0.27% 64
2014
Q3
$7.15M Buy
54,509
+43,764
+407% +$5.22M 0.24% 74
2014
Q2
$1.35M Sell
10,745
-13,265
-55% -$1.69M 0.05% 87
2014
Q1
$3.17M Hold
24,010
0.1% 97
2013
Q4
$2.82M Buy
+24,010
New +$2.63M 0.08% 104

Other funds holding BHC

Chilton Investment Company's BHC Position: Q2 2017 in Review

Chilton Investment Company sold out of Bausch Health (BHC) in Q2 2017, closing a stake of 120,000 shares — an estimated $1.32M sold.

Chilton Investment Company first reported a position in BHC in Q4 2013 and held it in 6 quarters. The position peaked at $7.8M in Q4 2014. 317 funds tracked by Wall St. Rank hold BHC as of Q2 2017.

  • Chilton Investment Company reported no remaining Bausch Health position as of Q2 2017 after selling out during the quarter.
  • Chilton Investment Company sold 120,000 Bausch Health shares in Q2 2017, an estimated $1.32M.
  • Chilton Investment Company first reported a position in Bausch Health in Q4 2013 and held it in 6 quarters.
  • Chilton Investment Company's Bausch Health position peaked at $7.8M in Q4 2014.
  • 317 funds tracked by Wall St. Rank held Bausch Health as of Q2 2017.

Based on Chilton Investment Company's 13F filing for Q2 2017, filed 9 Aug 2017.